Diagnosed with type 1 diabetes about a year ago, Ryan Ward was accepted into an innovative clinical trial underway at the Diabetes Research Institute. The POSEIDON Study is testing whether two oral medications (vitamin D and omega-3) may slow-down or stop the immune system’s attack and preserve Ryan’s insulin-producing cells. Ryan and his dad talk more about the trial and what they’re seeing so far.

Email This Post Email This Post